The RESTORE trial: what did we learn about multiple sclerosis?

Neurology. 2014 Apr 29;82(17):e155-7. doi: 10.1212/WNL.0000000000000423.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Drug Administration Schedule
  • Humans
  • Immunologic Factors / therapeutic use*
  • Multiple Sclerosis / therapy*
  • Natalizumab
  • Randomized Controlled Trials as Topic
  • Secondary Prevention
  • United States

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Natalizumab